期刊文献+

关注不断更新的房颤管理理念——《2012年ESC房颤治疗指南》解读 被引量:1

在线阅读 下载PDF
导出
摘要 目前,大体估计心房颤动(简称房颤)患者已占发达国家人口的1.5%~2%,我国的患病率约为0.77%,房颤患者的平均年龄也在逐步上升,男性高于女性,是临床上最常见的心律失常之一。房颤患者发生卒中与充血性心力衰竭的风险分别是正常人群的5倍与3倍,同时其所导致的住院率和病死率也在逐步上升,
作者 林加锋 李进
出处 《浙江医学》 CAS 2012年第20期1623-1626,1649,共5页 Zhejiang Medical Journal
  • 相关文献

参考文献14

  • 1Camm A J, Kirchhof P, Lip G Y, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)[J]. Europace, 2010,12:1360-1420.
  • 2Camm A J, Kirchhof P, Lip G Y, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC)[J]. Europace, 2010,12:1360 - 1420.
  • 3Fitzmaurice D A, Hobbs F D, Jowett S, et al. Screening vs routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial[J]. Br Med J, 2007,335:383.
  • 4Hobbs F D, Fitzmaurice D A, Mant J, et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) vs. routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study[J]. Health Technol Assess, 2005,9:1-74.
  • 5Potpara T S, Polovina M M, Licina M M, et al. Reliable identification of 'truly low' thromboembolic risk in patients initially diagnosed with 'lone' atrial fibrillation: the Belgrade Atrial Fibrillation Study[J]. Circ Arrhythm Electrophysiol ,2012,5:319-326.
  • 6Olesen J B, Torp-Pedersen C, Hansen M L, et ai. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study[J].Thromb Haemost,2012,107:1172-1179.
  • 7Van Staa T P, Setakis E, Di Tanna G L, et al. A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice[J]. J Thromb Haemost, 2011,9:39 - 48.
  • 8Mant J, Hobbs F D, Fletcher K, et al. Warfarin vs aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA: a randomised controlled trial[J]. Lancet, 2007, 370:493- 503.
  • 9Rash A, Downes T, Portner R, et al. A randomised controlled trial of warfarin vs. aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO) [J]. Age Ageing, 2007,36:151-156.
  • 10Friberg L, Rosenqvist M, Lip G Y. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation Cohort study [J]. Eur Heart J ,2012,33:1500-1510.

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部